Moreover, CD163 is implicated in the pathogenesis of various cancers, including chronic lymphocytic leukemia, multiple myeloma, meningioma, Hodgkin’s lymphoma, and colorectal cancer33–37. The gene discussed is CD163; the disease is B-cell chronic lymphocytic leukemia.